Clinical Trials Browser

Phase 1/2 × Leukemia × plitidepsin × Clear all

NCT00780143 2018-11-09

Clinical Study of Plitidepsin (Aplidin®) in Combination With Cytarabine in Patients With Relapsed/Refractory Leukemia

Phase 1/2 Terminated

3 enrolled 6 charts

Other hematologic neoplasm

Leukemia, Neoplasms